Bank of America’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,771
| Closed | -$2.3K | – | 8286 |
|
|
2025
Q2 | $2.3K | Sell |
1,771
-16,673
| -90% | -$20.1K | ﹤0.01% | 7415 |
|
|
2025
Q1 | $25.6K | Sell |
18,444
-10,648
| -37% | -$23.3K | ﹤0.01% | 6902 |
|
|
2024
Q4 | $66.6K | Buy |
29,092
+8,258
| +40% | +$21.9K | ﹤0.01% | 6549 |
|
|
2024
Q3 | $56.7K | Buy |
20,834
+174
| +0.8% | +$425 | ﹤0.01% | 6510 |
|
|
2024
Q2 | $48.3K | Buy |
20,660
+10,962
| +113% | +$35K | ﹤0.01% | 6524 |
|
|
2024
Q1 | $45.5K | Sell |
9,698
-12,243
| -56% | -$63.6K | ﹤0.01% | 6552 |
|
|
2023
Q4 | $107K | Buy |
21,941
+7,481
| +52% | +$31.1K | ﹤0.01% | 6352 |
|
|
2023
Q3 | $67.2K | Buy |
14,460
+8,517
| +143% | +$48.9K | ﹤0.01% | 6401 |
|
|
2023
Q2 | $43.9K | Sell |
5,943
-657
| -10% | -$4.39K | ﹤0.01% | 6506 |
|
|
2023
Q1 | $54K | Sell |
6,600
-262,905
| -98% | -$2.75M | ﹤0.01% | 6481 |
|
|
2022
Q4 | $2.58M | Buy |
269,505
+93,200
| +53% | +$1.15M | ﹤0.01% | 4027 |
|
|
2022
Q3 | $2.07M | Buy |
176,305
+159,190
| +930% | +$2.1M | ﹤0.01% | 4243 |
|
|
2022
Q2 | $220K | Buy |
17,115
+7,581
| +80% | +$78.6K | ﹤0.01% | 6019 |
|
|
2022
Q1 | $105K | Sell |
9,534
-4,072
| -30% | -$47.2K | ﹤0.01% | 6837 |
|
|
2021
Q4 | $209K | Buy |
13,606
+4,993
| +58% | +$65.3K | ﹤0.01% | 6473 |
|
|
2021
Q3 | $121K | Buy |
8,613
+3,799
| +79% | +$63.5K | ﹤0.01% | 6612 |
|
|
2021
Q2 | $93K | Buy |
+4,814
| New | +$99.4K | ﹤0.01% | 6549 |
|
Bank of America's AKYA Position: Q3 2025 in Review
Bank of America sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 1,771 shares — an estimated $2.3K sold.
Bank of America first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $2.58M in Q4 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Bank of America reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Bank of America sold 1,771 Akoya BioSciences shares in Q3 2025, an estimated $2.3K.
- Bank of America first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Bank of America's Akoya BioSciences position peaked at $2.58M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.